Dose-finding trials are essential to drug development as they establish recommended doses for later-phase testing. We aim to motivate wider use of model-based designs for dose-finding, such as the continual reassessment method (CRM).
We carried out a literature review of dose-finding designs and conducted a survey to identify perceived barriers to their implementation.
We describe the benefits of model-based designs (flexibility,...
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Springer Nature Publisher's website
- British Journal of Cancer Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Love et al.
- Copyright date:
Copyright © 2017 Love et al. This work is licensed under the Creative Commons Attribution 4.0 International License.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/